Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan Minister Wants Provisional Approval Of Medical Devices Used In Clinical Trials

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Japan should allow provisional approval for medical devices used in clinical trials instead of waiting for formal Ministry of Health, Labor and Welfare certification, said Akira Amari, the country's minister on regulatory reform

You may also be interested in...

MHLW Drafts GCP Guidance To Strengthen Human Subject Protections For Device Trials

TOKYO - Japan's Ministry of Health, Labor and Welfare Nov. 11 posted a draft ministry ordinance on good clinical practices that would strengthen the country's human subject protections for participants in clinical device trials. The measure calls for independent institutional review boards to approve device trials

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts